Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MYCOPHENOLIC ACID DR 360 MG TB

mycophenilic acid
$0.2234per EA

Strength

360 mg/1

Manufacturer

Archis Pharma LLC

NDC

72819015608

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MYCOPHENOLIC ACID

Approval Type

Generic (ANDA)

FDA Application

ANDA091248

On Market Since

2/21/2022

Pharmacological Classes

Antimetabolite Immunosuppressant

Price History

1W

0.0%

1M

+0.5%

3M

-7.6%

6M

-9.5%

1Y

-27.4%

3Y

-39.0%

5Y

N/A

All

-39.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MYCOPHENOLIC ACID DR 180 MG TB
Generic
00904678504•Major Pharmaceuticals
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
00904678561•Major Pharmaceuticals
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
16729026129•Accord Healthcare Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
24979016044•TWi Pharmaceuticals, Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
59651062108•Aurobindo Pharma Limited
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
60505296507•Apotex Corp.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
67877042612•Ascend Laboratories, LLC
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
68084090721•American Health Packaging
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
70377003911•Biocon Pharma Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
70377012611•Biocon Pharma Inc.
$0.1200
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy